Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk Rades

Showing results (351-360 of 586) with videos related to

Pageof 59
Sort By:
Oral Oncology|May 22, 2016
Do we need 5-FU in addition to cisplatin for chemoradiation of locally advanced head-and-neck cancer?Dirk Rades, Daniel Seidl, Stefan Janssen, et al.
Anticancer Research|April 30, 2016
Importance of Chemotherapy and Radiation Dose After Microscopically Incomplete Resection of Stage III/IV Head and Neck CancerDaniel Seidl, Stefan Janssen, Primoz Strojan, et al.
Anticancer Research|April 30, 2016
Hypofractionated Radiotherapy for Breast Cancer Including Risk-adapted Boost: Update on Tolerance and Efficacy of an Accelerated START A RegimeStefan Janssen, Christoph Glanzmann, Stephanie Lang, et al.
Cancer|November 13, 2009
The role of postoperative radiotherapy for the treatment of gangliogliomasDirk Rades, Lena Zwick, Jan Leppert, et al.
Anticancer Research|December 4, 2018
Outcomes After Radiotherapy Alone for Metastatic Spinal Cord Compression in Patients with Oligo-metastatic Breast CancerDirk Rades, Annika Panzner, Stefan Janssen, et al.
International Journal of Radiation Oncology, Biology, Physics|October 2, 2007
Locally advanced stage IV squamous cell carcinoma of the head and neck: impact of pre-radiotherapy hemoglobin level and interruptions during radiotherapyDirk Rades, Monika Stoehr, Nadja Kazic, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 3, 2004
Is there a life-long risk of brachial plexopathy after radiotherapy of supraclavicular lymph nodes in breast cancer patients?Amira Bajrovic, Dirk Rades, Fabian Fehlauer, et al.
Molecular Cancer|November 22, 2015
Dasatinib blocks transcriptional and promigratory responses to transforming growth factor-beta in pancreatic adenocarcinoma cells through inhibition of Smad signalling: implications for in vivo mode of actionTobias Bartscht, Benjamin Rosien, Dirk Rades, et al.
BMC Cancer|December 21, 2021
A prospective interventional study investigating sleep disorders prior to and during adjuvant radiotherapy for breast cancerDirk Rades, Carlos A Narvaez, Liesa Dziggel, et al.
Anticancer Research|October 1, 2021
Risk Factors for Sleep Disturbances in Patients Scheduled for Radiotherapy of Head-and-Neck CancerDirk Rades, Svenja Kopelke, Tamer Soror, et al.
Pageof 59

Showing results (351-360 of 586) with videos related to

Sort By:
Pageof 59
Oral Oncology|May 22, 2016
Do we need 5-FU in addition to cisplatin for chemoradiation of locally advanced head-and-neck cancer?Dirk Rades, Daniel Seidl, Stefan Janssen, et al.
Anticancer Research|April 30, 2016
Importance of Chemotherapy and Radiation Dose After Microscopically Incomplete Resection of Stage III/IV Head and Neck CancerDaniel Seidl, Stefan Janssen, Primoz Strojan, et al.
Anticancer Research|April 30, 2016
Hypofractionated Radiotherapy for Breast Cancer Including Risk-adapted Boost: Update on Tolerance and Efficacy of an Accelerated START A RegimeStefan Janssen, Christoph Glanzmann, Stephanie Lang, et al.
Cancer|November 13, 2009
The role of postoperative radiotherapy for the treatment of gangliogliomasDirk Rades, Lena Zwick, Jan Leppert, et al.
Anticancer Research|December 4, 2018
Outcomes After Radiotherapy Alone for Metastatic Spinal Cord Compression in Patients with Oligo-metastatic Breast CancerDirk Rades, Annika Panzner, Stefan Janssen, et al.
International Journal of Radiation Oncology, Biology, Physics|October 2, 2007
Locally advanced stage IV squamous cell carcinoma of the head and neck: impact of pre-radiotherapy hemoglobin level and interruptions during radiotherapyDirk Rades, Monika Stoehr, Nadja Kazic, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 3, 2004
Is there a life-long risk of brachial plexopathy after radiotherapy of supraclavicular lymph nodes in breast cancer patients?Amira Bajrovic, Dirk Rades, Fabian Fehlauer, et al.
Molecular Cancer|November 22, 2015
Dasatinib blocks transcriptional and promigratory responses to transforming growth factor-beta in pancreatic adenocarcinoma cells through inhibition of Smad signalling: implications for in vivo mode of actionTobias Bartscht, Benjamin Rosien, Dirk Rades, et al.
BMC Cancer|December 21, 2021
A prospective interventional study investigating sleep disorders prior to and during adjuvant radiotherapy for breast cancerDirk Rades, Carlos A Narvaez, Liesa Dziggel, et al.
Anticancer Research|October 1, 2021
Risk Factors for Sleep Disturbances in Patients Scheduled for Radiotherapy of Head-and-Neck CancerDirk Rades, Svenja Kopelke, Tamer Soror, et al.
Pageof 59